Research Project
Grant-in-Aid for Challenging Exploratory Research
Br-77 is one of Auger electron emitting radionuclide. Auger electron emitting radiopharmaceuticals are attractive for targeted nanoirradiation therapy. The DNA of malignant cells is particularly suitable target. The aim of this study is to evaluate 5-[^<77> Br] bromo-4'-thio-2'-deoxyuridine(^<77> Br-BTdU) as a radiopharmaceutical for DNA targeted nanoirradiation therapy and(2S,αS)-2-(α-(2-[^<77> Br] bromophenoxy) benzyl) morpholine((SS)-^<77> Br-BPB) as a radiopharmaceuticals for cell membrane targeted nanoirradiation therapy.^<77> Br-BTdU is a potential radiopharmaceutical for DNA targeted nanoirradiation therapy and(SS)-^<77> Br-BPBM is also a potential radiopharmaceuticals for cell membrane targeted nanoirraidation therapy.
All 2012 2011 2010
All Journal Article (2 results) (of which Peer Reviewed: 2 results) Presentation (25 results) Patent(Industrial Property Rights) (2 results)
Nucl Med Biol
Volume: 37 Issue: 4 Pages: 395-404
10.1016/j.nucmedbio.2009.12.011
Nucl Med Biol.
Volume: 37 Pages: 395-404